Saturday 13 July 2013

Working Toward a Cure for HIV: Matthew Uhlenkott of Aurora



Dr. Matthew Uhlenkott of Aurora is a resident anesthesiologist at the University of Colorado. Much of Matthew Uhlenkott of Aurora’s past research has focused on the treatment of HIV. Matthew Uhlenkott of Aurora became interested in studying the continued mortality of HIV-infected patients despite highly active antiretroviral therapy (HAART). In 2005, Matthew Uhlenkott of Aurora presented a poster at the Thirteenth Annual AIDS Malignancy Consortium: “Causes of Death in the HAART Era: Perspectives From a Combined HIV and Hematology/Oncology Primary Care Practice.” Since then, Matthew Uhlenkott of Aurora has continued his research on the HAART era of HIV treatment.

In 2008, Matthew Uhlenkott of Aurora published a paper in the American Journal of Medical Sciences: “Causes of Death in the Era of Highly Active Antiretroviral Therapy: A Retrospective Analysis of a Hybrid Hematology-Oncology and HIV Practice and the Seattle/King County Adult/Adolescent Spectrum of HIV-Related Diseases Project.” In this study, Matthew Uhlenkott of Aurora found that non-AIDS defining illness were a major source of death in 60% of the cohort from the Virginia Mason Medical Center and in 45% of the cohort from the Seattle portion of the Adult and Adolescent Spectrum of Diseases Project. Matthew Uhlenkott of Aurora’s paper indicates that HIV-infected patients are continuing to die from non-AIDS related causes despite undetectable HIV viral loads and fairly well-preserved immune function.

Matthew Uhlenkott of Aurora believes that finding better treatments and a cure for HIV/AIDS should be a priority for the medical community. HIV/AIDS has caused about 35 million deaths, and 34 million people were living with HIV globally at the end of 2011. Sub-Saharan Africa has been most severely impacted by the HIV/AIDS epidemic and, as a doctor who is concerned about providing medicine internationally to those most in need, Matthew Uhlenkott of Aurora is committed to working toward a better understanding of HIV/AIDS.

No comments:

Post a Comment